Analysts: For-profit payers to grow Medicare, Medicaid businesses regardless of health law

Large for-profit health insurers can still run profitable Medicare and Medicaid businesses depsite whether senators pass the Republican healthcare bill this summer, analysts told CNBC.

Advertisement

Following the GOP’s decision to postpone voting on the Better Care Reconciliation Act, Citi analysts issued a buy rating for Hartford, Conn.-based Aetna and Louisville, Ky.-based Humana. They said the companies have the potential to increase profits from their government businesses. 

Medicaid represents 13 percent of Aetna’s revenue, the report states. The payer aims to increase that following recent managed care contract wins in Nevada and Virginia. As for Humana, Medicare reflects roughly 80 percent of its revenue. Analysts predict the payer can still grow its Medicare business as more adults reach age 65 and qualify for the program.

In a research note obtained by CNBC, Citi analyst Ralph Giacobbe said, “When you step back from the uncertainty created by the current political landscape and consider the larger economics around how managed Medicaid helps states to save money and improve outcomes, it is likely to continue to be an indispensable piece of the solution for the future of healthcare.”

For the full report, click here

More articles on payer issues:
California Medicaid plan introduces new email policy after court ruling
Nebraska managed care company faces sanctions for ‘serious deficiencies’
UnitedHealthcare to invest $18.3M in Michigan affordable housing complexes

Advertisement

Next Up in Uncategorized

  • Health systems are navigating a rapidly evolving healthcare environment where patient safety is shaped by both longstanding challenges and emerging…

  • Since 2020, CHS has announced or completed the sale of 35 hospitals:  2025 2024 2023 2022 2021 In July 2021,…

  • Sacroiliac joint fusion technology is advancing, and the data shows it’s efficacy across different medtech companies. Five notes: 1. Tenon…

Advertisement

Comments are closed.